Intimation to stock Exchanges

Quick Explore

Update on Cipla and Amgen reach a settlement on pending litigation involving generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg)
20th Jul 2020
Allotment of 37,102 equity shares under ESOS
16th Jul 2020
Notice of Board Meeting – Newspaper Publication
16th Jul 2020
Notice of Board Meeting – August 2020
15th Jul 2020
Press release - Cipla receives final approval for generic version of Shire’s Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL)
14th Jul 2020
Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix for Development and Commercialization of Pulmazole
13th Jul 2020
Schedule of Analyst / Institutional Investor Meetings
29th Jun 2020
Press Release – Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs
29th Jun 2020
Schedule of Analyst and Institutional Investors meetings
26th Jun 2020
Schedule of Analyst and Institutional Investors meetings
23rd Jun 2020
 
BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.